GO	[-5.24 -0.52]	[-0.52 -0.24]	[-0.24 -0.12]	[-0.12 -0.03]	[-0.03 0.00]	[0.00 0.00]	[0.00 0.06]	[0.06 0.18]	[0.18 0.37]	[0.37 0.76]	[0.76 8.14]
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-6.401	0.266	14.752	12.123	-0.459	-6.401	0.367	-1.011	-1.960	-4.267	-4.251
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-4.638	-0.580	11.142	7.626	-0.311	-5.817	1.813	0.291	-2.007	-4.638	-4.623
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-5.496	-0.420	9.539	11.278	0.292	-6.735	1.005	-0.722	-2.628	-3.165	-2.158
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-3.355	1.282	5.589	12.481	0.889	-5.731	0.574	-1.281	-1.578	-4.779	-5.713
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	-4.522	0.406	7.491	9.630	0.406	-5.456	1.700	-0.543	-2.144	-3.765	-4.506
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-4.037	1.661	6.479	7.876	-0.596	-7.863	1.661	-0.756	-0.946	-3.437	-2.902
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-3.867	2.145	13.552	3.422	-1.828	-3.867	1.379	-0.957	-2.686	-2.686	-2.212
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-3.072	0.462	6.815	6.815	0.353	-7.361	0.901	0.462	-0.595	-2.578	-6.066
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	-6.322	-0.674	3.620	6.416	-1.308	-6.322	3.620	2.083	-0.525	-1.062	-4.507
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	-2.728	-0.528	10.903	4.227	0.319	-6.151	1.325	0.319	-0.697	-4.049	-4.034
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	-3.032	-0.647	10.116	7.592	-0.389	-5.709	1.144	-0.389	-1.011	-2.167	-4.152
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-2.852	0.388	8.767	9.903	-0.581	-5.105	0.388	-0.759	-1.234	-2.341	-3.446
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-2.982	1.998	3.865	8.538	0.291	-4.900	0.735	-0.613	-1.432	-3.790	-3.778
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-4.059	0.458	9.029	7.292	0.331	-4.059	0.458	-2.043	-1.254	-2.573	-1.601
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-2.192	-0.829	6.607	3.826	-1.260	-8.072	1.124	3.160	-0.302	-2.192	-3.046
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-3.906	0.767	10.815	4.626	0.379	-3.906	0.767	-0.882	-1.097	-3.315	-2.789
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-4.385	-1.830	6.225	8.126	-0.993	-3.710	0.440	1.690	-0.270	-1.230	-3.694
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	-3.943	0.301	6.666	6.666	-0.301	-3.943	1.318	-0.642	-1.650	-2.919	-2.189
EPPERT_PROGENITOR EPPERT_PROGENITOR	-1.231	2.177	7.799	5.743	-1.231	-5.734	0.426	-1.953	-1.953	-0.959	-2.414
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	-4.630	1.293	8.096	5.372	-0.560	-4.630	-0.432	0.277	0.277	-2.831	-2.372
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-2.477	0.364	5.443	9.343	-0.354	-5.067	0.500	-0.677	-1.533	-1.186	-3.110
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	-2.947	0.426	6.351	7.459	-0.430	-4.858	0.577	-0.598	-2.319	-2.319	-0.805
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	-3.319	2.693	4.109	5.196	-1.707	-3.319	0.520	-0.397	-0.397	-3.319	-2.355
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	-2.862	-1.363	-1.363	-0.406	-0.252	-2.862	5.701	9.199	-0.252	-1.363	-1.956
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	-1.632	2.703	5.075	5.534	-1.296	-3.796	0.522	0.283	-1.296	-2.034	-4.661
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-1.278	0.412	2.977	9.642	-0.940	-4.026	0.997	0.279	-1.278	-2.994	-2.984
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	-1.612	0.270	4.355	7.717	-0.334	-6.916	-0.712	-0.437	1.046	-0.889	-3.700
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-1.836	-0.301	9.249	5.977	-0.301	-2.510	-0.301	-1.336	-1.336	-2.510	-1.828
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-3.090	0.622	3.444	6.544	-0.408	-6.797	0.622	1.510	-1.045	-1.278	-2.610
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	-0.609	2.132	9.834	3.657	-0.771	-3.468	-0.473	-1.186	-2.094	-1.447	-2.931
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-1.966	0.557	5.040	7.404	-0.522	-3.652	0.557	-0.351	-1.966	-1.966	-2.649
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	-3.102	-2.178	0.451	4.217	0.344	-6.125	4.217	1.482	1.264	-0.776	-3.087
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	-2.280	0.910	4.090	8.309	0.245	-1.466	-0.949	-1.466	-0.949	-2.280	-2.274
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-3.936	0.926	5.714	5.714	0.355	-3.936	0.260	0.601	-1.534	-2.277	-1.866
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-2.962	0.745	1.635	5.815	-0.940	-5.692	0.580	1.914	0.745	-2.395	-2.949
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-3.676	1.007	5.986	3.207	0.322	-4.775	-0.405	0.795	-0.567	-1.034	-3.664
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-4.267	-0.459	1.403	1.403	0.791	-5.183	1.178	3.168	1.914	-1.276	-5.166
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-1.637	-0.318	4.626	2.879	-0.882	-6.401	0.767	2.879	0.285	-1.347	-3.889
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-2.982	-0.443	2.676	5.246	1.163	-4.900	1.417	0.413	-0.443	-2.982	-2.340
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-1.028	0.635	8.000	2.275	-0.659	-4.203	0.396	-0.829	1.765	-3.061	-3.576
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-5.053	1.046	1.439	3.006	-1.612	-8.239	-0.334	1.439	1.660	-0.437	-0.330
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	-2.228	0.568	0.319	6.976	0.433	-4.949	1.568	0.319	1.103	-1.452	-4.933
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-0.399	-1.403	-0.293	-1.403	-2.570	-6.651	-1.403	1.482	1.729	2.909	4.808
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	-1.468	0.985	5.908	5.461	-0.319	-3.196	0.505	0.284	-2.197	-3.196	-2.185
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-1.756	2.828	5.661	2.187	-1.406	-6.067	0.597	0.457	-1.113	-0.869	-2.161
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-3.223	-1.044	0.309	4.783	-0.660	-6.283	0.662	4.783	1.385	-1.044	-1.279
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-0.697	1.832	4.643	3.449	-1.153	-6.151	0.433	-0.528	0.319	-0.904	-4.034
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-2.745	2.078	2.992	4.061	-1.241	-4.706	2.365	0.355	-0.782	-1.534	-2.731
DAZARD_UV_RESPONSE_CLUSTER_G6 DAZARD_UV_RESPONSE_CLUSTER_G6	-0.834	1.431	0.985	7.294	-2.117	-5.984	0.985	0.628	-0.478	-2.606	-1.066
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	-1.580	-0.523	3.908	8.196	-1.117	-3.153	0.412	-0.341	-0.341	-1.580	-2.209
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	-2.734	0.395	3.598	4.008	0.282	-3.404	1.325	1.091	-0.610	-2.188	-4.237
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-4.246	2.343	3.629	5.171	-0.732	-3.580	0.485	-0.436	-0.327	-1.424	-2.089
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	-2.425	-0.735	-1.559	-0.292	-1.559	-1.953	1.880	11.365	1.120	-1.231	-0.729
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	-1.999	0.519	4.988	3.867	0.519	-2.903	0.737	-0.422	-1.999	-2.903	-1.387
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-2.281	-3.223	-0.660	-0.660	-0.660	-6.283	0.662	2.114	3.322	3.322	0.823
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	1.124	-1.028	-4.203	-3.061	2.555	7.058	0.301	-2.597	-0.659	-0.517	0.789
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-3.145	1.702	1.702	7.869	-0.537	-3.145	-0.373	0.507	-1.381	-1.029	-1.820
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	0.593	-1.681	-1.386	-2.411	-1.681	-0.335	-2.860	-0.728	1.484	1.962	9.067
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-1.045	-1.045	8.400	3.912	-1.045	-4.039	0.560	0.327	-0.829	-0.648	-1.939
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-2.770	0.914	2.901	5.886	-0.258	-3.776	0.504	-0.391	-0.391	-2.065	-2.056
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-3.444	-1.308	3.880	3.399	0.467	-1.803	-0.442	2.523	-0.289	-1.803	-2.465
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-2.312	-0.957	-2.312	0.399	-1.214	-5.066	0.292	2.307	4.469	2.621	0.403
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-2.696	1.231	6.076	3.018	0.246	-1.477	0.539	-0.538	-1.477	-2.696	-1.991
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-3.145	-1.029	2.381	-0.250	0.507	-4.192	2.028	2.028	1.702	-0.752	-3.134
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-2.529	0.498	6.661	1.689	0.315	-2.529	0.498	-0.287	-0.470	-1.677	-2.522
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	-2.862	1.336	2.484	4.503	-0.406	-1.963	1.336	-0.626	-0.935	-1.363	-2.854
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-1.487	0.451	5.416	4.602	-2.606	-3.677	0.884	-0.354	-0.468	-0.608	-1.796
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-1.858	0.492	3.534	7.158	-0.260	-2.432	0.492	-0.771	-1.051	-1.407	-2.423
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-3.194	0.253	3.338	4.904	-0.541	-1.612	0.253	0.253	0.798	-3.194	-1.605
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	0.310	0.310	-1.173	-1.832	-2.256	-0.712	-1.173	-1.474	-0.541	3.400	9.071
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	-1.712	0.701	4.590	4.590	0.301	-1.712	0.301	-0.489	-1.712	-1.712	-2.564
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-2.903	-1.393	2.012	2.872	0.519	-2.903	3.353	-0.264	0.342	-1.999	-1.387
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	-1.452	0.725	4.643	3.449	-1.452	-2.728	0.433	1.325	-0.284	-2.728	-2.716
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-0.489	-1.152	2.949	8.749	-0.762	-2.571	0.301	-0.762	-1.152	-1.152	-0.758
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	-0.458	0.842	2.932	5.814	-0.458	-5.971	0.559	-0.739	-1.975	-0.458	-1.363
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	-3.193	1.963	2.578	3.272	-0.638	-3.193	0.985	0.359	0.482	-1.706	-3.179
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	-1.188	0.954	4.947	4.080	-0.703	-4.483	0.330	0.330	-0.703	-1.188	-2.354
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	-1.933	0.404	-1.029	1.943	-0.731	-2.621	4.590	1.604	1.023	-1.029	-3.600
WIELAND_UP_BY_HBV_INFECTION WIELAND_UP_BY_HBV_INFECTION	-2.500	-4.317	-0.411	-0.810	-1.460	-1.097	-0.411	0.629	2.608	4.315	1.916
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	-1.948	2.561	3.102	2.066	-0.431	-1.948	-0.431	0.883	-1.191	-1.948	-1.943
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	2.401	-1.221	-1.852	-4.669	0.770	0.268	-0.975	-2.250	-0.337	3.034	3.395
WHITFIELD_CELL_CYCLE_G1_S WHITFIELD_CELL_CYCLE_G1_S	-1.439	1.492	1.021	4.255	-0.486	-4.367	2.706	0.255	-0.867	-1.125	-2.819
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	-1.891	0.388	2.174	3.079	-1.891	-1.891	1.096	2.174	-0.374	-2.779	-1.884
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	2.536	-1.535	-1.926	-2.395	1.144	0.933	-0.940	-2.395	-0.719	-0.396	6.333
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-1.006	0.249	2.429	3.223	-0.733	-4.151	0.707	2.429	-0.521	-1.798	-2.356
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	-0.924	-0.510	5.867	4.892	-0.510	-2.509	-0.924	0.644	-0.694	-1.985	-1.201
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-1.397	-2.197	4.932	2.616	-1.397	-2.197	1.319	0.272	-0.332	-0.332	-1.392
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	0.409	0.226	-1.124	-1.124	-1.124	-1.124	-1.865	-1.865	1.320	0.654	7.602
TIEN_INTESTINE_PROBIOTICS_6HR_UP TIEN_INTESTINE_PROBIOTICS_6HR_UP	-1.431	-0.921	0.258	0.435	-0.921	-1.431	2.543	4.817	1.274	-2.239	-2.233
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-2.197	-0.893	5.606	2.616	-0.893	-2.197	1.319	0.272	-0.893	-0.893	-0.888
MORI_PRE_BI_LYMPHOCYTE_UP MORI_PRE_BI_LYMPHOCYTE_UP	-2.400	-0.266	5.104	4.554	-1.253	-2.400	0.502	-0.266	-0.888	-1.253	-0.610
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	-2.145	-0.652	-0.652	1.656	-1.093	-2.145	2.872	2.538	3.225	-1.731	-2.134
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-0.582	-0.418	4.435	2.412	-2.913	-2.288	0.983	1.765	-0.582	-1.383	-2.278
ODONNELL_TFRC_TARGETS_DN ODONNELL_TFRC_TARGETS_DN	-2.034	1.051	5.075	5.075	-0.784	-1.296	-0.594	-0.320	-1.296	-1.632	-1.287
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	-0.867	0.389	3.576	1.797	-1.327	-5.372	0.293	1.797	0.950	-0.687	-2.760
RHODES_CANCER_META_SIGNATURE RHODES_CANCER_META_SIGNATURE	-1.783	0.440	1.928	6.279	-0.527	-2.654	0.274	0.274	0.274	-1.783	-1.777
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-1.362	-0.535	2.203	5.736	0.476	-2.156	0.720	-0.316	-0.865	-1.362	-2.150
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	-1.225	0.848	4.205	2.485	-1.990	-1.990	0.351	0.571	-0.451	-1.225	-1.984
FARMER_BREAST_CANCER_CLUSTER_2 FARMER_BREAST_CANCER_CLUSTER_2	-1.367	0.231	8.272	1.130	-0.385	-1.367	0.231	-0.385	-1.367	-1.367	-0.730
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	1.612	-0.545	-0.893	-4.964	0.392	4.089	-1.691	-0.704	-0.893	-0.545	3.388
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	1.218	0.311	-2.288	-1.787	1.765	5.905	-0.792	-2.913	-1.383	-0.418	0.598
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	3.473	-1.074	-2.466	-1.888	1.080	3.473	0.334	-3.220	-1.074	-0.270	0.653
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-2.288	-0.418	1.479	2.412	-0.582	-3.714	0.775	3.154	0.775	-1.383	-2.278
ABRAMSON_INTERACT_WITH_AIRE ABRAMSON_INTERACT_WITH_AIRE	-1.824	0.239	4.009	2.807	1.370	-1.090	0.239	-1.090	-0.650	-1.824	-1.819
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	-0.886	-0.275	0.582	2.151	-0.515	-4.910	1.351	3.132	0.329	-0.381	-3.998
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	-1.612	-0.797	2.875	4.353	0.798	-2.253	0.253	1.055	-0.797	-1.612	-2.245
LY_AGING_OLD_DN LY_AGING_OLD_DN	-1.501	0.233	1.957	6.624	0.397	-2.322	0.397	-1.501	-0.622	-0.622	-1.496
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.560	-0.560	-0.898	-0.898	-1.659	-4.630	0.277	-0.327	0.751	3.489	4.991
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-0.771	-0.771	3.018	1.856	0.967	-3.693	0.736	1.528	-0.771	-1.477	-2.686
BROWN_MYELOID_CELL_DEVELOPMENT_UP BROWN_MYELOID_CELL_DEVELOPMENT_UP	-2.774	-2.304	-0.621	0.457	-1.010	-2.774	-0.356	-0.261	3.641	2.046	2.968
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	-2.637	0.964	1.930	4.824	-0.360	-3.226	-0.258	-0.652	1.173	-0.851	-2.134
KAMMINGA_EZH2_TARGETS KAMMINGA_EZH2_TARGETS	-1.699	0.501	5.077	3.082	-0.318	-0.991	-0.318	-0.574	-0.574	-1.699	-1.695
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	0.340	0.611	-1.872	-0.512	-1.487	-2.896	-2.336	0.611	0.611	0.976	6.487
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	-3.977	0.457	1.897	2.498	0.457	-4.871	1.626	-0.503	0.457	-0.869	-0.498
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	-1.737	1.333	1.803	1.559	-0.436	-5.038	0.485	0.485	2.343	-2.523	-1.146
KAUFFMANN_DNA_REPLICATION_GENES KAUFFMANN_DNA_REPLICATION_GENES	-1.429	1.351	3.881	1.864	0.329	-3.293	0.742	0.742	-1.781	-0.886	-2.685
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-1.681	0.269	0.896	1.484	0.593	-3.971	0.593	4.149	0.736	-1.681	-2.845
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-2.331	-0.813	0.336	-0.366	-1.926	-4.004	0.445	2.594	0.336	4.744	0.580
DAZARD_RESPONSE_TO_UV_SCC_DN DAZARD_RESPONSE_TO_UV_SCC_DN	-2.878	-0.281	1.801	2.456	-2.256	-3.676	0.795	2.456	0.322	-0.405	-0.768
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-0.761	0.353	0.590	6.815	-0.959	-4.315	0.901	0.901	-0.345	-0.959	-1.772
BROWNE_HCMV_INFECTION_14HR_UP BROWNE_HCMV_INFECTION_14HR_UP	-2.012	0.599	1.591	2.130	-2.012	-2.455	2.130	1.591	0.347	-0.482	-3.580
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	1.299	0.293	-1.045	-0.408	-4.236	-1.549	-2.217	0.293	0.496	1.510	5.304
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	-2.239	-1.431	0.258	-0.578	-0.348	-1.431	3.053	5.480	0.258	-0.348	-1.426
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-1.966	-3.652	0.256	-1.053	-0.751	-1.448	-0.522	2.263	2.656	2.263	0.764
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	-2.637	-0.652	-0.360	0.348	-0.851	-4.832	-0.258	1.404	4.397	1.656	-0.356
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-2.436	0.679	2.179	3.467	-0.278	-3.402	1.477	-1.280	-0.278	-0.911	-0.906
SCIBETTA_KDM5B_TARGETS_DN SCIBETTA_KDM5B_TARGETS_DN	-0.577	0.538	1.949	5.881	-2.326	-2.326	-0.244	0.538	-0.383	-1.675	-1.192
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	2.901	1.086	-1.508	-1.508	-0.661	1.086	-2.445	-2.445	-1.164	0.679	3.301
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	-2.319	-1.815	-0.301	-1.077	-2.319	-0.430	-1.077	4.369	1.447	2.724	0.582
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	-0.949	0.637	3.512	2.973	0.637	-2.280	0.416	-2.280	-0.949	-0.600	-1.461
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	-0.633	-0.633	-1.771	-2.436	-0.427	0.326	-1.280	-0.911	0.326	3.955	5.032
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	-2.658	-1.053	0.390	0.557	0.995	-3.652	1.899	1.565	0.995	0.557	-2.649
KERLEY_RESPONSE_TO_CISPLATIN_UP KERLEY_RESPONSE_TO_CISPLATIN_UP	0.409	-0.676	-1.124	-1.865	-0.676	-1.865	-1.124	-0.392	0.409	4.553	3.298
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-2.043	0.990	3.468	2.368	-0.273	-4.059	0.331	0.458	0.458	-1.609	-1.601
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	1.850	-0.496	-0.905	-0.496	-1.186	-2.477	-0.905	-0.905	-1.186	2.161	5.969
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	0.412	-0.676	-1.081	-3.451	-0.676	-1.646	-1.081	-0.395	1.431	2.193	5.432
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	0.479	-0.432	-1.659	-0.327	-1.997	-2.831	-1.997	0.277	1.992	4.574	1.755
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	0.301	-1.100	-1.362	-1.669	4.526	4.139	-0.877	-1.362	-1.669	-0.405	1.201
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-0.731	-1.420	-1.029	0.782	-0.338	-1.933	1.604	3.596	2.712	-1.029	-2.612
WAKASUGI_HAVE_ZNF143_BINDING_SITES WAKASUGI_HAVE_ZNF143_BINDING_SITES	-0.921	0.664	3.053	3.053	-0.921	-2.239	0.944	-0.348	-0.348	-1.431	-2.233
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-1.055	1.218	-0.792	2.076	-0.291	-3.714	-0.792	4.905	0.439	-1.787	-0.577
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	-1.271	0.604	1.825	6.710	-0.566	-1.855	-0.566	0.250	-0.359	-1.855	-1.266
JIANG_HYPOXIA_NORMAL JIANG_HYPOXIA_NORMAL	-1.654	0.442	-0.458	1.610	-0.919	-4.403	3.242	-0.264	3.242	-0.739	-1.120
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	-2.351	0.291	3.050	2.676	-1.843	-2.351	1.417	-0.312	0.561	0.291	-2.340
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	0.756	0.934	-1.318	-1.048	-2.976	-1.318	-2.012	-0.636	0.934	1.851	4.621
KANG_DOXORUBICIN_RESISTANCE_UP KANG_DOXORUBICIN_RESISTANCE_UP	-0.921	0.664	2.543	3.602	0.944	-2.239	0.435	-0.921	-1.431	-1.431	-1.426
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	-1.907	0.389	1.271	1.677	-0.702	-1.907	1.271	1.677	0.389	-1.907	-1.901
BROCKE_APOPTOSIS_REVERSED_BY_IL6 BROCKE_APOPTOSIS_REVERSED_BY_IL6	-1.731	-1.731	0.469	0.777	-2.637	-3.940	0.777	2.224	1.404	1.656	0.352
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	-2.306	0.477	0.627	3.783	0.801	-3.546	0.477	1.463	-0.257	-0.671	-2.852
TAKAO_RESPONSE_TO_UVB_RADIATION_DN TAKAO_RESPONSE_TO_UVB_RADIATION_DN	-1.739	-0.696	0.749	2.159	0.398	-4.068	2.921	1.224	-1.739	-0.491	-0.487
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	0.576	-0.338	-1.933	-1.933	1.023	5.126	-0.505	-2.621	-1.420	0.782	0.788
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	1.055	-0.829	-4.816	-2.833	-0.648	0.706	0.327	-0.648	0.560	1.723	3.219
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-1.907	-0.411	2.640	3.791	-0.228	-1.158	1.271	-0.411	-1.158	-0.702	-1.901
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	-1.271	2.673	1.825	1.458	-0.860	-1.855	0.604	0.846	-0.359	-2.737	-1.848
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	0.283	0.391	-0.320	0.391	-2.515	-3.796	-0.784	-0.442	0.852	-0.320	6.531
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-1.191	1.225	3.102	3.688	-0.729	-1.191	0.370	-0.729	-0.729	-1.191	-1.943
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-3.372	-0.451	-0.634	1.220	-1.540	-2.603	1.789	2.840	1.220	0.576	-0.863
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	-0.506	-0.856	-1.086	0.328	-3.663	-2.512	-0.506	0.723	1.089	2.665	3.359
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	1.245	-0.867	-1.439	-1.819	0.643	0.490	-3.511	-1.819	0.820	2.370	2.384
WEI_MIR34A_TARGETS WEI_MIR34A_TARGETS	-0.667	0.597	2.187	2.828	-0.371	-4.871	0.597	0.759	-0.371	-0.667	-2.655
PYEON_HPV_POSITIVE_TUMORS_UP PYEON_HPV_POSITIVE_TUMORS_UP	0.384	0.384	4.677	2.477	-2.331	-2.331	0.384	0.259	-0.506	-0.984	-1.760
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	-1.261	0.511	3.023	2.642	-0.357	-3.523	-0.357	1.109	-0.357	-0.508	-2.729
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	0.783	0.633	-1.949	0.783	-3.284	-1.615	-1.615	-0.687	0.502	3.576	2.066
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-2.172	0.457	2.828	2.828	-1.113	-2.172	-0.503	1.377	0.597	-0.371	-2.655
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	-0.910	-0.240	3.008	1.728	-0.390	-2.820	1.062	1.062	-0.390	-1.927	-1.920
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	-0.663	-0.663	-0.663	-0.663	2.696	4.517	0.362	-0.663	-0.663	-0.663	-0.661
SASAKI_ADULT_T_CELL_LEUKEMIA SASAKI_ADULT_T_CELL_LEUKEMIA	-1.926	2.014	0.336	3.961	-0.813	-4.779	0.889	-0.366	-0.269	-0.269	-0.628
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	0.473	0.473	-4.303	-1.906	-0.427	-0.551	-0.873	-0.326	0.278	1.686	5.196
LE_EGR2_TARGETS_UP LE_EGR2_TARGETS_UP	-0.493	0.261	3.076	3.919	-0.685	-3.485	0.701	0.380	-1.237	-0.930	-1.230
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-0.447	1.942	2.298	2.298	-0.897	-3.943	-0.897	0.816	-0.447	-1.227	-0.891
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	-2.903	-1.393	0.737	2.425	-0.422	-1.999	1.636	1.636	0.737	-0.961	-0.956
MAYBURD_RESPONSE_TO_L663536_DN MAYBURD_RESPONSE_TO_L663536_DN	-0.949	0.245	2.473	1.232	-0.949	-2.280	1.601	1.601	-0.600	-2.280	-0.945
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	2.619	0.643	-2.576	-2.089	0.265	0.643	-1.054	-1.340	-0.623	-0.465	4.535
EPPERT_HSC_R EPPERT_HSC_R	0.445	0.768	0.768	1.440	-3.263	-4.097	-0.983	1.191	2.008	-0.983	-0.279
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	-1.633	0.452	0.452	1.416	-0.343	-5.934	0.571	2.671	0.859	0.350	-1.621
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	-0.373	0.239	1.798	-1.090	-0.373	-1.824	0.430	3.385	0.998	-1.824	-1.819
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-1.511	-1.188	0.954	1.666	-0.526	-4.483	-0.703	2.577	1.406	0.763	-0.915
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	2.034	0.289	-1.868	-1.868	0.435	0.831	-3.527	-0.981	-0.313	0.831	2.427
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-0.566	0.311	2.623	2.286	-0.292	-5.275	-0.292	0.749	0.432	-0.761	-1.652
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-0.265	-1.487	-0.265	-1.872	-1.167	0.464	-0.687	-1.872	-0.265	2.969	5.035
KIM_LRRC3B_TARGETS KIM_LRRC3B_TARGETS	-1.243	-0.640	-1.243	-1.243	-0.640	-0.320	-1.243	0.283	2.991	2.991	0.884
TANG_SENESCENCE_TP53_TARGETS_DN TANG_SENESCENCE_TP53_TARGETS_DN	-0.977	0.233	7.368	0.612	0.233	-1.501	-0.382	-0.382	-0.382	-2.322	-0.379
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	-0.434	1.075	1.791	2.676	-0.434	-1.064	-1.064	1.791	-2.446	-1.064	-1.601
ELVIDGE_HIF1A_TARGETS_UP ELVIDGE_HIF1A_TARGETS_UP	-0.390	0.372	2.119	4.034	-1.927	-1.927	-0.240	0.790	-0.240	-1.332	-1.920
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-1.173	-0.541	-0.292	0.421	-2.759	-4.085	0.554	1.300	1.539	3.042	-0.289
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-0.289	-1.308	-0.442	-1.803	-1.308	-1.803	-0.652	-0.289	1.768	4.926	1.447
STEIN_ESRRA_TARGETS_DN STEIN_ESRRA_TARGETS_DN	-0.301	-1.514	1.827	4.179	-1.143	-2.568	-0.438	2.156	-0.617	-0.438	-1.137
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-1.706	-3.193	-0.834	-0.638	-1.074	-0.350	-1.074	1.963	1.963	2.578	1.442
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-1.336	1.112	4.840	0.856	-1.336	-2.510	-0.301	1.112	-0.958	-0.301	-1.329
MISSIAGLIA_REGULATED_BY_METHYLATION_UP MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-2.072	-1.635	-0.983	-1.277	-0.552	-0.983	0.321	-0.400	3.415	3.415	1.449
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	0.311	-1.003	-1.003	-1.003	-0.412	-2.637	-2.101	0.749	0.749	3.362	2.998
AMIT_SERUM_RESPONSE_60_MCF10A AMIT_SERUM_RESPONSE_60_MCF10A	0.362	-0.247	-0.416	0.564	-1.035	-2.405	-2.405	-1.035	1.456	3.806	0.567
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	0.372	0.372	1.044	3.894	-1.416	-3.475	-0.641	2.411	-0.641	-0.849	-1.097
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	-1.214	0.721	3.544	3.982	-0.479	-1.595	0.542	-0.668	-1.214	-0.909	-1.586
SANA_RESPONSE_TO_IFNG_UP SANA_RESPONSE_TO_IFNG_UP	-0.314	-0.314	-0.732	-1.517	-1.517	-1.517	-1.064	-0.732	1.466	3.554	3.083
LIAN_LIPA_TARGETS_6M LIAN_LIPA_TARGETS_6M	0.520	-1.225	-1.225	-1.707	-0.397	-0.397	-0.865	-0.596	-0.255	0.724	7.709
BROWNE_HCMV_INFECTION_18HR_UP BROWNE_HCMV_INFECTION_18HR_UP	-0.877	0.522	1.191	2.448	-1.669	-4.927	-0.689	2.160	-0.689	0.301	0.527
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-2.009	-0.451	2.114	3.665	-0.634	-3.372	1.491	-0.312	-0.451	-0.634	-0.447
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	-2.760	2.636	1.009	3.242	-1.975	-2.342	0.559	-0.458	-0.264	-0.586	-0.261
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-0.978	-0.484	2.102	1.610	-0.978	-5.634	-0.371	0.677	1.847	0.425	-0.778
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-1.090	0.239	1.370	4.677	0.239	-1.824	0.430	0.430	-1.824	-0.650	-1.086
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-1.999	-0.538	3.463	3.018	0.967	-0.771	0.539	-0.538	-0.538	-1.477	-1.991
IVANOVSKA_MIR106B_TARGETS IVANOVSKA_MIR106B_TARGETS	-1.966	-0.522	0.759	0.557	-1.966	-2.658	0.557	0.995	4.510	-0.351	-0.518
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-0.851	-1.731	-2.145	-1.384	0.612	0.612	-1.093	-0.360	-0.258	4.824	2.237
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	-1.393	0.997	3.867	2.425	-0.422	-0.961	0.342	-0.422	-0.422	-1.999	-1.992
NAKAMURA_CANCER_MICROENVIRONMENT_DN NAKAMURA_CANCER_MICROENVIRONMENT_DN	-0.392	2.204	3.288	0.409	-0.392	-1.865	0.226	0.409	-1.865	-1.865	-0.390
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	1.236	0.423	-1.321	-1.321	-1.976	-0.662	-1.063	-1.976	1.236	3.158	2.242
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-1.005	1.988	0.419	1.644	-0.711	-3.568	0.595	2.363	-0.711	-0.711	-1.385
JAIN_NFKB_SIGNALING JAIN_NFKB_SIGNALING	-0.732	3.071	1.466	1.466	-0.732	-3.070	-0.314	0.642	-0.732	-0.314	-2.136
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	0.594	-0.983	-0.400	-1.635	-2.072	0.321	-1.635	-0.552	-0.282	3.415	3.838
MEISSNER_NPC_HCP_WITH_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K27ME3	0.538	-0.842	-2.326	-1.198	2.753	3.681	-0.383	-1.675	-0.842	-0.383	0.753
ALCALA_APOPTOSIS ALCALA_APOPTOSIS	-3.610	0.267	0.576	-0.338	-0.338	-1.933	1.943	3.140	0.404	0.267	-1.413
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2 DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	-1.815	-0.598	1.730	4.834	0.959	-2.319	-0.430	0.577	-0.598	-1.408	-0.593
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-0.432	0.479	1.508	1.741	-1.114	-5.447	0.606	-0.432	1.741	-1.659	0.374
DAIRKEE_CANCER_PRONE_RESPONSE_BPA DAIRKEE_CANCER_PRONE_RESPONSE_BPA	-0.837	0.498	2.767	2.767	-0.513	-0.837	-0.301	0.750	-2.114	-2.114	-0.510
LIN_NPAS4_TARGETS_UP LIN_NPAS4_TARGETS_UP	-0.510	0.318	2.520	2.227	-1.623	-4.073	0.318	1.456	0.547	-0.845	-1.312
YU_MYC_TARGETS_UP YU_MYC_TARGETS_UP	-1.782	0.715	2.896	2.353	-0.624	-1.782	0.254	0.715	-0.624	-1.057	-1.053
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	1.328	0.262	-1.164	-2.445	-1.928	0.262	-0.343	-0.343	-1.508	2.901	2.916
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	-1.259	-0.271	1.938	4.096	1.137	-0.782	-0.271	-0.782	-0.472	-2.031	-1.255
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	-1.739	0.339	0.701	3.537	0.701	-3.360	0.937	0.339	-0.266	-0.614	-1.732
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-1.731	0.348	1.656	2.872	-0.652	-3.940	1.656	-0.360	0.612	-0.851	-0.845
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-1.623	0.547	1.695	1.695	-0.845	-4.853	-0.662	1.236	1.456	-0.385	-0.655
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	-0.625	0.384	3.160	1.298	-1.392	-2.766	2.130	0.860	-0.831	-1.392	-1.076
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	1.226	-1.616	0.320	-1.616	0.858	1.656	-0.925	-1.616	-0.283	-0.925	2.151
SMID_BREAST_CANCER_LUMINAL_A_UP SMID_BREAST_CANCER_LUMINAL_A_UP	2.826	-0.473	-1.868	-1.364	0.435	-0.473	-1.364	-2.547	1.366	1.366	1.088
BYSTROEM_CORRELATED_WITH_IL5_DN BYSTROEM_CORRELATED_WITH_IL5_DN	-1.035	0.564	1.844	1.844	-0.247	-2.405	-0.668	1.844	-0.416	-0.416	-2.398
APPEL_IMATINIB_RESPONSE APPEL_IMATINIB_RESPONSE	0.231	-0.733	-0.733	-1.367	-0.733	-0.733	-1.367	0.453	2.669	4.000	-0.383
TOOKER_GEMCITABINE_RESISTANCE_DN TOOKER_GEMCITABINE_RESISTANCE_DN	-0.510	1.037	2.452	0.644	-0.510	-5.108	0.353	0.828	0.353	-0.255	-1.976
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	0.721	-0.354	0.344	-1.211	-1.807	-2.606	-0.976	-0.776	1.971	0.721	4.240
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	-0.269	-0.366	1.752	-0.269	-3.355	-4.004	0.722	-0.366	2.295	0.889	-0.361
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	1.679	1.971	-1.661	-1.003	-0.412	0.311	-0.761	-2.637	-1.661	1.166	2.299
MATTIOLI_MGUS_VS_PCL MATTIOLI_MGUS_VS_PCL	-2.605	-0.744	1.440	1.440	1.440	1.712	0.967	-0.282	-1.277	-2.072	-1.626
NAGASHIMA_EGF_SIGNALING_UP NAGASHIMA_EGF_SIGNALING_UP	-0.235	-1.006	0.587	-0.645	-0.645	-2.363	-2.363	-0.235	2.339	1.503	1.510
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-1.225	-0.255	0.520	-0.255	-1.707	-3.319	0.353	1.243	4.109	-0.255	-0.394
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	-1.271	-1.271	-0.860	-2.737	-1.271	0.604	0.250	2.231	1.825	1.458	0.408
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-1.528	-1.837	-0.517	-0.517	-1.028	-2.597	0.301	1.124	3.486	1.321	1.547
KATSANOU_ELAVL1_TARGETS_UP KATSANOU_ELAVL1_TARGETS_UP	0.292	0.392	-1.382	-2.468	-1.118	-0.310	-0.893	-0.893	0.509	2.128	4.897
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-1.888	-1.434	0.334	2.289	0.334	-3.220	-0.270	0.648	2.289	0.849	-1.068
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-0.835	0.262	0.876	5.508	-0.546	-1.819	0.627	-1.241	-0.344	0.422	-1.813
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	-1.153	0.903	-0.284	-0.284	-0.528	-4.049	-1.807	1.325	3.449	0.433	0.437
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	-0.911	-0.911	0.873	5.057	-0.406	-0.911	0.217	-0.911	0.217	-0.911	0.493
LENAOUR_DENDRITIC_CELL_MATURATION_DN LENAOUR_DENDRITIC_CELL_MATURATION_DN	-2.766	0.384	0.677	-0.461	-0.625	-4.290	0.273	0.273	1.067	2.130	1.307
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	-0.828	-0.828	0.256	-0.351	-0.351	-0.828	0.991	5.527	0.256	-0.828	-0.826
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-0.464	0.260	1.810	2.992	-1.241	-2.745	2.078	0.355	-0.992	-0.347	-1.866
LIU_CMYB_TARGETS_UP LIU_CMYB_TARGETS_UP	-2.224	-0.752	-0.328	1.162	-1.201	-2.224	-0.752	0.965	3.784	1.615	-0.437
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	2.130	-0.652	-1.308	-1.308	-0.652	-1.308	-2.473	0.657	0.467	1.768	2.140
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	1.080	-0.624	-0.875	-1.201	-0.875	-2.164	-0.624	-1.201	2.346	1.080	3.164
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-2.288	-0.792	-0.792	-0.418	-2.288	-0.582	-0.418	3.986	1.479	0.439	1.488
GAVIN_FOXP3_TARGETS_CLUSTER_P3 GAVIN_FOXP3_TARGETS_CLUSTER_P3	-0.452	-0.767	0.770	-1.512	0.268	-2.715	-2.250	0.364	0.770	3.376	1.853
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	-1.872	0.281	0.281	1.661	-0.322	-3.017	1.137	2.630	0.281	0.400	-2.372
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-1.243	0.283	2.361	2.361	0.283	-1.243	0.880	-0.320	-0.640	-1.243	-1.240
WARTERS_IR_RESPONSE_5GY WARTERS_IR_RESPONSE_5GY	-0.472	-0.782	-0.271	-1.259	-0.271	-2.031	-2.031	0.546	1.938	1.938	1.519
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	-2.031	0.334	-0.472	0.546	-0.472	-0.472	4.742	0.334	0.814	-0.782	-2.026
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	-0.848	0.400	0.914	5.669	-1.457	-0.848	-0.629	-0.456	-1.457	1.387	-1.113
LIAN_LIPA_TARGETS_3M LIAN_LIPA_TARGETS_3M	-0.329	-1.211	-0.810	-1.783	-0.810	0.274	-0.527	-0.329	0.274	0.651	6.988
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	-2.073	0.521	0.317	1.461	0.781	-2.073	2.847	0.317	-0.492	-0.810	-1.289
RUIZ_TNC_TARGETS_DN RUIZ_TNC_TARGETS_DN	-0.465	1.222	4.097	1.459	-0.340	-3.868	-0.340	-0.465	-1.054	-0.465	-0.811
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	1.256	0.278	-1.078	-0.699	0.367	-4.303	-1.906	0.473	1.256	2.741	0.479
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-2.654	0.440	-0.527	2.349	-0.527	-1.211	2.808	0.440	0.440	-0.329	-1.777
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-1.654	-0.351	1.009	1.610	-0.351	-3.236	1.009	2.636	0.692	-1.654	-1.120
BOYLAN_MULTIPLE_MYELOMA_D_DN BOYLAN_MULTIPLE_MYELOMA_D_DN	-1.739	-0.266	-0.412	0.701	-2.400	-2.400	0.502	3.537	1.209	-0.266	0.342
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	-0.986	2.366	0.966	1.961	-2.035	-1.424	0.712	0.499	0.328	-2.035	-0.981
SAGIV_CD24_TARGETS_DN SAGIV_CD24_TARGETS_DN	0.409	-1.124	-1.124	-1.124	-1.124	-1.865	0.654	-0.392	2.204	0.654	2.732
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	-0.820	-0.369	-0.820	-1.171	0.243	-3.236	-0.369	-0.369	2.813	2.389	1.031
WILCOX_RESPONSE_TO_PROGESTERONE_UP WILCOX_RESPONSE_TO_PROGESTERONE_UP	-2.369	-1.566	2.542	1.678	0.275	-2.883	-0.447	1.430	-0.594	0.644	0.381
BROWNE_INTERFERON_RESPONSIVE_GENES BROWNE_INTERFERON_RESPONSIVE_GENES	-0.374	-0.885	-0.586	-1.891	-1.302	-1.891	-0.374	0.581	2.609	2.609	1.102
TSAI_RESPONSE_TO_RADIATION_THERAPY TSAI_RESPONSE_TO_RADIATION_THERAPY	-0.363	0.480	-1.326	0.247	-0.363	-0.363	-1.326	-1.326	-0.702	1.647	4.150
DIRMEIER_LMP1_RESPONSE_LATE_UP DIRMEIER_LMP1_RESPONSE_LATE_UP	-2.322	0.877	-0.977	0.612	-0.622	-2.322	0.233	2.895	0.877	-0.622	0.615
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	-1.355	2.071	0.524	2.813	-1.006	-2.365	-0.521	1.438	0.249	-1.798	-0.357
SESTO_RESPONSE_TO_UV_C0 SESTO_RESPONSE_TO_UV_C0	-2.071	-1.595	0.392	2.031	-0.334	-2.671	1.426	2.031	0.721	-0.334	-0.903
WARTERS_RESPONSE_TO_IR_SKIN WARTERS_RESPONSE_TO_IR_SKIN	-1.280	-0.278	-0.633	-0.633	-0.633	-3.402	-0.633	1.812	1.812	2.179	0.488
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP	-0.301	-0.581	-0.424	-1.322	-1.023	-1.023	-3.333	0.923	1.935	2.246	1.657
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	-0.336	1.083	1.928	1.477	-1.741	-1.741	1.083	-0.336	-1.741	-0.336	-0.596
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	-1.027	-0.269	1.507	2.910	-1.578	-3.355	0.336	2.014	-0.269	-0.486	-0.806
GAJATE_RESPONSE_TO_TRABECTEDIN_DN GAJATE_RESPONSE_TO_TRABECTEDIN_DN	0.566	2.866	1.521	0.991	-0.351	-0.828	-0.828	-0.828	-0.828	-0.828	-0.826
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-1.214	0.721	3.130	1.715	0.270	-2.671	1.426	-0.909	-0.909	-0.479	-1.207
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	-1.077	1.231	1.856	1.528	-0.364	-0.771	-0.364	-1.999	-2.696	-0.538	1.865
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	-0.977	2.454	0.414	1.846	-0.418	-3.725	0.710	1.325	-0.566	-1.252	-0.970
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	3.031	-1.635	-2.072	-2.072	0.594	1.440	-0.400	-0.983	-0.282	-0.282	1.723
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	0.301	-1.077	-0.598	-0.810	-1.408	-1.815	-1.408	1.447	2.368	3.102	0.430
MORI_PRE_BI_LYMPHOCYTE_DN MORI_PRE_BI_LYMPHOCYTE_DN	-1.643	-0.559	0.381	0.381	-0.820	-2.290	-0.369	4.270	1.313	0.772	-1.165
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	1.510	0.795	-0.405	-2.878	-1.760	-0.567	-1.358	0.322	-0.567	1.007	3.223
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	0.395	-0.722	-1.446	-0.310	-0.420	-1.779	-0.310	-2.170	0.517	2.827	3.533
WANG_CISPLATIN_RESPONSE_AND_XPC_UP WANG_CISPLATIN_RESPONSE_AND_XPC_UP	-0.701	-1.973	2.291	5.020	-0.882	-0.882	-0.548	-0.422	-0.548	-0.882	0.774
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	-0.953	-0.953	-0.434	0.457	-0.953	-0.434	0.457	0.821	4.846	-0.434	-0.950
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	0.301	0.410	1.769	0.540	-1.497	-3.393	0.691	1.769	1.059	-0.728	-2.273
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	0.269	-0.336	0.269	3.591	-1.024	-1.741	0.269	1.477	0.476	-1.024	-1.736
DER_IFN_ALPHA_RESPONSE_UP DER_IFN_ALPHA_RESPONSE_UP	-2.144	-0.732	-0.732	1.153	0.288	-2.144	-0.732	0.878	2.619	1.815	-0.727
KIM_GLIS2_TARGETS_UP KIM_GLIS2_TARGETS_UP	-0.458	0.856	-0.958	-1.336	-0.958	-1.336	-1.336	-0.458	0.451	3.332	2.898
KESHELAVA_MULTIPLE_DRUG_RESISTANCE KESHELAVA_MULTIPLE_DRUG_RESISTANCE	-2.473	1.144	-0.442	0.657	-0.289	-1.803	0.313	0.313	4.390	-0.442	-1.302
JIANG_VHL_TARGETS JIANG_VHL_TARGETS	-2.584	0.806	-0.326	1.988	0.419	-2.584	2.363	0.278	-0.326	0.278	-1.385
DEN_INTERACT_WITH_LCA5 DEN_INTERACT_WITH_LCA5	-1.077	-0.520	2.792	2.148	-1.077	-1.077	0.371	0.684	-0.241	-1.077	-0.518
RAMASWAMY_METASTASIS_UP RAMASWAMY_METASTASIS_UP	-1.855	1.458	2.231	0.405	-0.566	-1.271	2.231	0.604	-1.271	-0.860	-1.266
VERNELL_RETINOBLASTOMA_PATHWAY_UP VERNELL_RETINOBLASTOMA_PATHWAY_UP	-0.961	2.012	2.012	2.012	-0.264	-1.999	0.519	-0.422	-1.999	-0.647	-0.956
LEE_AGING_CEREBELLUM_UP LEE_AGING_CEREBELLUM_UP	-2.436	-0.427	-0.911	1.477	-1.771	-0.633	0.326	0.909	-0.633	0.326	3.971
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-0.672	-0.408	-0.528	0.386	-0.672	-5.784	0.293	1.738	1.983	0.926	0.391
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	-1.328	-0.301	-2.114	0.498	-0.837	-2.114	0.750	2.270	0.498	1.412	0.304
OUILLETTE_CLL_13Q14_DELETION_DN OUILLETTE_CLL_13Q14_DELETION_DN	-0.622	-0.977	-2.322	0.612	-0.977	-0.622	0.397	0.612	3.993	1.190	-0.973
SWEET_KRAS_ONCOGENIC_SIGNATURE SWEET_KRAS_ONCOGENIC_SIGNATURE	-1.966	-1.966	-0.522	0.256	0.256	-2.658	0.759	1.899	2.263	0.390	0.562
SMIRNOV_RESPONSE_TO_IR_2HR_UP SMIRNOV_RESPONSE_TO_IR_2HR_UP	-0.893	-1.397	-1.397	0.691	-0.893	-2.197	0.980	-0.332	1.706	1.706	0.985
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	-0.389	-0.389	-1.011	-0.647	-0.506	-4.170	-0.647	0.309	2.589	1.792	1.806
BUFFA_HYPOXIA_METAGENE BUFFA_HYPOXIA_METAGENE	-2.073	-0.285	1.095	2.847	-0.285	-1.294	1.095	1.095	-1.294	-0.810	-0.806
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	0.560	-0.240	-0.910	-0.390	-1.927	-1.332	-1.332	-0.606	1.728	0.560	4.049
FINETTI_BREAST_CANCER_KINOME_RED FINETTI_BREAST_CANCER_KINOME_RED	-0.663	0.362	3.556	1.292	0.762	-0.663	-0.663	-0.663	-0.663	-0.663	-0.661
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	-0.234	-1.492	-1.492	0.646	-0.828	-0.828	-0.234	-0.453	0.380	5.060	0.382
BILD_CTNNB1_ONCOGENIC_SIGNATURE BILD_CTNNB1_ONCOGENIC_SIGNATURE	-2.290	0.381	3.269	1.997	-0.369	-1.171	0.243	-1.171	0.558	0.381	-1.637
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	2.046	0.578	0.253	-1.144	-0.541	1.055	-0.797	-1.612	-0.541	-2.253	2.888
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	2.160	-0.689	-1.362	-0.689	0.660	0.402	-3.483	-1.100	0.301	0.660	2.770
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	0.756	-0.715	-1.093	-0.715	-0.452	-0.715	-0.452	0.756	-2.488	3.629	1.374
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	-0.241	-1.077	-1.077	-1.077	-0.241	-1.077	0.371	-0.520	1.578	3.507	0.373
KAYO_AGING_MUSCLE_DN KAYO_AGING_MUSCLE_DN	-4.059	0.458	-0.388	3.080	0.331	-1.254	0.990	1.218	-0.727	-0.727	-0.270
CHANDRAN_METASTASIS_TOP50_UP CHANDRAN_METASTASIS_TOP50_UP	-0.925	0.320	2.688	2.688	0.320	-1.616	-0.525	-0.525	0.320	-0.525	-1.612
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	0.815	0.309	0.526	-0.660	-1.288	-2.718	-1.044	-0.513	-0.836	2.685	3.014
BRUINS_UVC_RESPONSE_MIDDLE BRUINS_UVC_RESPONSE_MIDDLE	-2.298	0.971	-0.336	0.398	-0.962	-1.739	1.507	3.788	0.269	-0.491	-0.956
EGUCHI_CELL_CYCLE_RB1_TARGETS EGUCHI_CELL_CYCLE_RB1_TARGETS	-0.911	0.217	3.338	1.356	0.490	-0.911	0.490	-0.406	-0.911	-0.911	-0.909
GAVIN_FOXP3_TARGETS_CLUSTER_P6 GAVIN_FOXP3_TARGETS_CLUSTER_P6	-1.534	0.349	3.794	2.496	-0.391	-2.065	0.349	-0.572	-1.127	-0.572	-0.255
BASSO_CD40_SIGNALING_UP BASSO_CD40_SIGNALING_UP	-1.407	-0.771	-0.771	-1.051	-0.553	-1.407	-0.385	0.872	0.872	0.492	5.492
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-1.259	-1.259	-0.782	1.137	1.137	-2.031	0.546	2.411	0.546	0.334	-1.255
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	-1.294	1.095	3.398	1.095	-0.810	-1.294	1.095	-1.294	-0.810	-0.810	-0.283
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-0.961	2.012	-0.264	2.872	-0.647	-1.999	-0.422	1.297	-0.264	-0.422	-1.992
PARK_APL_PATHOGENESIS_DN PARK_APL_PATHOGENESIS_DN	-1.990	-0.755	0.571	-0.451	-1.225	-1.225	-0.451	0.351	1.565	3.588	0.354
DELPUECH_FOXO3_TARGETS_DN DELPUECH_FOXO3_TARGETS_DN	-0.549	-0.958	1.594	3.813	-0.549	-1.658	0.820	-0.958	-0.300	0.302	-0.954
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	0.967	-0.771	-1.999	-2.696	-1.077	0.736	-0.771	0.246	1.231	1.856	1.239
BURTON_ADIPOGENESIS_12 BURTON_ADIPOGENESIS_12	-0.702	-0.702	0.480	4.139	-0.702	-1.326	0.793	0.793	-1.326	0.247	-0.699
GUTIERREZ_MULTIPLE_MYELOMA_UP GUTIERREZ_MULTIPLE_MYELOMA_UP	-1.492	-1.492	1.859	0.380	0.380	-1.492	0.984	1.859	-0.453	-0.828	-0.233
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-1.397	-0.556	-0.556	0.455	-0.893	-2.197	-0.556	1.319	3.695	0.272	0.695
CUI_GLUCOSE_DEPRIVATION CUI_GLUCOSE_DEPRIVATION	-2.529	-1.122	1.004	0.315	-0.738	-1.677	0.498	0.728	3.023	0.498	-0.467
AMIT_EGF_RESPONSE_480_HELA AMIT_EGF_RESPONSE_480_HELA	-1.201	-1.490	-0.581	0.787	-0.441	-3.867	0.492	0.965	2.145	0.276	1.627
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-0.614	0.339	2.230	1.516	-0.614	-3.360	1.516	0.339	-0.412	-1.253	-0.610
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	0.759	1.264	-2.658	-1.448	-0.522	0.557	-0.751	-0.751	-1.053	1.264	2.668
IKEDA_MIR133_TARGETS_UP IKEDA_MIR133_TARGETS_UP	-1.090	-1.090	0.684	3.385	0.430	-1.824	0.430	1.370	-0.373	-1.090	-0.647
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	3.340	-0.235	-1.536	-0.399	0.379	-1.536	-2.363	0.587	-0.399	0.587	0.849
ZHENG_IL22_SIGNALING_UP ZHENG_IL22_SIGNALING_UP	0.541	-0.434	-1.064	-0.434	-0.691	0.541	-1.606	-2.446	1.411	0.784	2.686
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	-0.626	-0.626	-1.363	-1.363	1.029	2.939	0.539	-0.626	-1.363	-0.626	2.495
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-1.005	-0.489	-0.326	1.052	0.806	-3.568	1.331	-0.489	2.363	-1.005	-0.323
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	-0.606	-0.606	0.324	-2.131	-1.176	-0.418	-1.176	-0.279	0.651	1.385	4.649
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	-0.222	-1.036	-1.036	-1.036	-1.036	-0.491	-0.491	0.398	1.149	2.916	1.153
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	-0.759	-0.581	1.016	0.513	-1.543	-3.460	-0.975	0.283	0.659	1.457	2.597
RODRIGUES_THYROID_CARCINOMA_DN RODRIGUES_THYROID_CARCINOMA_DN	0.243	0.381	2.813	-0.820	-1.643	-2.290	-1.171	-0.369	0.558	2.389	0.245
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	-1.117	1.387	1.724	1.724	0.598	-2.217	-0.341	-0.523	0.598	-2.217	-0.771
BILANGES_SERUM_RESPONSE_TRANSLATION BILANGES_SERUM_RESPONSE_TRANSLATION	-0.407	-1.409	-0.407	-0.765	0.716	-1.409	3.191	2.010	-0.407	0.216	-0.762
ALONSO_METASTASIS_UP ALONSO_METASTASIS_UP	-1.528	-0.517	0.396	4.551	0.301	-2.597	0.944	-0.517	0.781	0.301	-1.250
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	-1.517	-0.732	0.288	1.466	-0.488	-3.070	-1.064	1.466	0.642	1.466	0.449
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	1.024	1.638	-1.171	-3.236	0.772	0.558	-0.559	-1.643	-0.559	0.558	1.031
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	1.458	-0.359	-0.359	0.405	-1.855	0.250	-0.860	-0.359	-2.737	0.846	2.684
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-0.981	-0.981	0.289	1.082	-0.981	-3.527	-0.473	0.435	2.034	0.831	1.088
GAURNIER_PSMD4_TARGETS GAURNIER_PSMD4_TARGETS	-0.438	-2.035	-0.986	-1.424	0.328	-0.438	-0.668	-0.438	0.966	3.786	1.600
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	0.403	-0.430	-0.996	-0.996	-0.430	-0.767	-0.767	-1.274	-0.430	5.140	2.116
GOZGIT_ESR1_TARGETS_UP GOZGIT_ESR1_TARGETS_UP	2.081	-0.541	-1.173	1.081	-1.173	-0.921	-3.359	0.421	0.421	0.421	2.094
ELVIDGE_HYPOXIA_UP ELVIDGE_HYPOXIA_UP	0.412	-1.341	-0.676	1.015	-0.861	-2.413	-0.676	-0.861	3.116	2.193	0.417
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	-0.411	0.625	-1.907	-0.702	-0.411	-1.907	-0.411	-0.411	0.625	1.677	2.649
TAVOR_CEBPA_TARGETS_UP TAVOR_CEBPA_TARGETS_UP	-0.865	-1.362	-0.316	-0.316	-0.865	-1.362	1.364	-0.865	0.476	0.476	4.415
GENTILE_RESPONSE_CLUSTER_D3 GENTILE_RESPONSE_CLUSTER_D3	-0.332	1.319	0.272	1.706	-1.397	-1.397	0.455	2.616	-0.893	-0.893	-1.392
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-0.877	-0.301	0.301	4.526	-1.362	-2.922	0.660	0.522	0.818	-0.405	-0.683
DAZARD_RESPONSE_TO_UV_SCC_UP DAZARD_RESPONSE_TO_UV_SCC_UP	-1.487	-0.829	0.611	2.199	0.804	-3.296	0.312	0.447	1.027	0.611	-1.479
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	-1.271	0.846	1.458	0.846	0.846	-1.855	0.250	1.825	-1.271	-0.566	-1.848
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	1.169	0.646	0.801	0.801	0.292	-3.516	-0.545	2.128	-0.704	-0.310	-2.455
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	-0.622	-0.382	0.612	2.405	-0.382	-2.322	1.957	-0.622	0.877	-1.501	-0.619
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-0.893	-2.051	0.801	0.509	-0.704	-2.952	-0.893	0.801	1.381	0.801	2.142
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	-1.466	0.637	2.973	0.637	0.245	-2.280	-0.365	1.232	0.245	-0.949	-0.945
YAMAZAKI_TCEB3_TARGETS_DN YAMAZAKI_TCEB3_TARGETS_DN	-1.130	-0.351	3.242	2.932	-0.739	-2.342	-0.458	0.692	-0.264	-0.586	-0.911
LANG_MYB_FAMILY_TARGETS LANG_MYB_FAMILY_TARGETS	-1.202	-0.300	1.877	0.302	-0.610	-1.202	2.460	0.928	-0.300	-0.610	-1.198
RIEGE_DELTANP63_DIRECT_TARGETS_UP RIEGE_DELTANP63_DIRECT_TARGETS_UP	-0.959	-0.959	0.912	1.605	-1.953	-2.994	-0.407	1.120	0.727	1.605	-0.289
HU_ANGIOGENESIS_DN HU_ANGIOGENESIS_DN	-0.860	0.614	1.332	2.876	-1.533	-0.477	0.359	0.614	-0.477	-0.860	-1.529
GALE_APL_WITH_FLT3_MUTATED_UP GALE_APL_WITH_FLT3_MUTATED_UP	-0.691	1.075	1.411	2.213	-1.064	-2.446	-0.434	0.541	0.346	-0.260	-1.601
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	-1.322	0.563	-0.424	0.301	-2.130	-3.333	0.563	1.140	1.935	0.420	0.930
CHESLER_BRAIN_HIGHEST_EXPRESSION CHESLER_BRAIN_HIGHEST_EXPRESSION	0.254	-1.057	-0.624	3.486	0.453	-0.624	-1.057	2.353	0.254	-1.057	-1.053
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-1.097	-1.460	2.608	2.244	-0.280	-2.500	0.323	-0.280	1.053	-0.585	-0.580
MARTINEZ_RESPONSE_TO_TRABECTEDIN MARTINEZ_RESPONSE_TO_TRABECTEDIN	-0.810	3.991	1.095	0.781	-1.294	-1.294	0.521	-1.294	-0.285	-0.285	-0.806
LINDSTEDT_DENDRITIC_CELL_MATURATION_D LINDSTEDT_DENDRITIC_CELL_MATURATION_D	0.478	-1.712	-0.762	0.970	-1.712	-1.152	-1.152	0.701	1.284	0.301	2.484
MMS_MOUSE_LYMPH_HIGH_4HRS_UP MMS_MOUSE_LYMPH_HIGH_4HRS_UP	-0.828	-0.453	-0.234	3.619	0.380	-1.492	0.646	0.984	-1.492	-0.234	-0.825
LINDVALL_IMMORTALIZED_BY_TERT_UP LINDVALL_IMMORTALIZED_BY_TERT_UP	2.174	-2.779	0.238	-1.302	-0.374	-1.302	-0.586	0.818	1.096	0.238	1.102
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	-2.436	0.326	0.326	-0.911	-0.427	-2.436	-0.427	1.812	0.679	2.179	0.488
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	0.291	-0.996	0.291	-1.608	-0.767	-3.761	0.872	0.536	1.813	1.074	1.082
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	0.637	-0.365	-2.280	-0.949	1.232	0.910	-0.949	-0.600	-0.949	0.245	2.983
KOBAYASHI_EGFR_SIGNALING_6HR_DN KOBAYASHI_EGFR_SIGNALING_6HR_DN	-0.746	-0.298	-0.746	-0.746	-0.746	-0.746	-0.298	-0.298	2.399	0.655	2.405
OKUMURA_INFLAMMATORY_RESPONSE_LPS OKUMURA_INFLAMMATORY_RESPONSE_LPS	-1.010	0.551	0.429	3.407	-3.162	-1.854	0.429	0.849	0.551	0.326	-0.628
PECE_MAMMARY_STEM_CELL_DN PECE_MAMMARY_STEM_CELL_DN	0.612	-0.490	1.173	2.224	-0.851	-3.940	-0.360	1.173	0.612	-0.652	-1.086
CASTELLANO_NRAS_TARGETS_UP CASTELLANO_NRAS_TARGETS_UP	0.688	0.481	-1.012	-1.012	-1.455	-1.012	-1.455	-0.454	0.688	3.208	1.556
WEBER_METHYLATED_ICP_IN_SPERM_DN WEBER_METHYLATED_ICP_IN_SPERM_DN	-0.176	-0.538	-0.538	-0.538	-0.538	5.408	-0.538	-0.176	-0.176	-0.538	0.478
TIEN_INTESTINE_PROBIOTICS_2HR_DN TIEN_INTESTINE_PROBIOTICS_2HR_DN	-0.771	0.246	1.528	1.528	-1.999	-2.696	0.736	1.528	0.376	-0.538	-0.766
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	0.827	-1.918	-1.460	-1.097	-0.585	2.608	-0.280	-1.097	-0.411	1.053	1.916
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	-1.549	-1.091	0.850	0.428	-0.753	-2.180	1.769	-0.506	2.559	0.620	-0.502
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	-2.363	-1.006	0.587	-1.006	-0.399	-1.006	2.339	1.503	-0.235	1.151	-0.396
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-1.583	-0.751	1.846	1.097	-0.751	-3.027	0.710	1.097	0.710	0.710	-1.244
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	0.625	1.271	-0.702	-1.158	-1.907	-0.411	-0.702	-1.158	0.389	0.920	2.649
MIKKELSEN_ES_LCP_WITH_H3K4ME3 MIKKELSEN_ES_LCP_WITH_H3K4ME3	-0.350	-0.350	-2.117	-2.117	0.628	1.431	-1.074	-0.834	0.257	1.431	2.593
KAMIKUBO_MYELOID_CEBPA_NETWORK KAMIKUBO_MYELOID_CEBPA_NETWORK	-0.320	-0.640	-0.320	-1.243	-1.243	-0.640	0.283	-0.640	0.283	2.991	2.368
SERVITJA_LIVER_HNF1A_TARGETS_DN SERVITJA_LIVER_HNF1A_TARGETS_DN	1.588	-1.852	-2.715	-1.221	1.140	1.840	0.268	-0.767	0.364	-0.452	1.149
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-1.416	0.660	0.504	0.840	0.372	-4.328	0.660	1.522	0.372	0.504	-1.407
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	1.055	-0.355	-0.797	-1.144	-0.797	-0.797	-1.612	-0.797	0.798	1.055	3.845
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	1.949	-0.577	0.994	0.538	-0.577	-1.675	0.994	0.994	0.367	-2.326	-1.668
PEART_HDAC_PROLIFERATION_CLUSTER_DN PEART_HDAC_PROLIFERATION_CLUSTER_DN	-0.986	0.499	1.592	0.966	0.328	-2.945	0.712	1.259	-0.986	-0.276	-1.418
YANG_BREAST_CANCER_ESR1_BULK_UP YANG_BREAST_CANCER_ESR1_BULK_UP	-1.077	-1.077	0.684	1.088	-1.077	-0.520	-0.520	-1.077	1.088	1.578	0.687
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	0.358	-1.929	-1.335	-0.562	0.270	0.270	-1.095	-0.889	0.358	3.006	3.025
RICKMAN_HEAD_AND_NECK_CANCER_D RICKMAN_HEAD_AND_NECK_CANCER_D	2.222	-0.500	-1.575	-1.575	0.584	1.721	-0.500	-0.893	-0.500	-0.266	0.902
ONDER_CDH1_TARGETS_1_UP ONDER_CDH1_TARGETS_1_UP	-0.735	0.565	0.426	0.310	-0.959	-3.689	-0.959	-0.292	2.177	2.177	0.314
CHUNG_BLISTER_CYTOTOXICITY_UP CHUNG_BLISTER_CYTOTOXICITY_UP	-1.209	-0.396	0.320	4.444	-0.940	-1.209	-0.396	1.635	0.745	-0.719	-1.201
GREENBAUM_E2A_TARGETS_UP GREENBAUM_E2A_TARGETS_UP	-0.733	0.754	2.669	2.669	-0.385	-1.367	-0.733	-0.733	-0.385	-0.385	-0.730
LEE_EARLY_T_LYMPHOCYTE_DN LEE_EARLY_T_LYMPHOCYTE_DN	0.564	-1.035	-0.247	-1.571	-0.416	-1.571	-1.571	1.844	1.112	1.844	0.365
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	-0.958	-0.958	0.527	1.594	-0.549	-0.958	1.594	0.820	1.176	-0.958	-1.653
FUJII_YBX1_TARGETS_UP FUJII_YBX1_TARGETS_UP	-0.624	0.254	-1.057	-1.057	-1.057	0.254	-0.624	-1.057	0.715	2.896	2.362
BEIER_GLIOMA_STEM_CELL_DN BEIER_GLIOMA_STEM_CELL_DN	-1.271	0.250	-0.566	-0.566	-1.855	-1.271	-0.860	1.132	1.825	1.132	1.834
WU_CELL_MIGRATION WU_CELL_MIGRATION	0.514	-1.308	-0.851	-0.674	-0.402	-1.062	-1.062	-0.525	-0.302	3.280	3.300
CHOI_ATL_CHRONIC_VS_ACUTE_DN CHOI_ATL_CHRONIC_VS_ACUTE_DN	-0.324	-0.787	2.269	3.018	0.279	-0.787	-0.787	-0.324	-0.324	-0.787	-0.323
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP	-0.241	-0.241	-0.520	-0.520	-1.077	-1.077	-1.077	-0.241	0.371	2.792	2.154
BURTON_ADIPOGENESIS_6 BURTON_ADIPOGENESIS_6	-1.815	0.797	0.519	0.519	-1.508	-3.032	2.307	0.962	0.797	0.309	-0.640
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-0.733	-0.733	1.130	1.577	0.453	-1.367	0.754	0.453	0.754	-1.367	-1.364
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-0.668	-1.571	0.564	2.747	-0.668	-2.405	-0.247	0.362	1.456	0.362	-0.414
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	1.545	-1.274	-1.274	-0.311	-0.996	2.414	-0.580	-0.996	-0.767	-0.311	2.761
LEIN_ASTROCYTE_MARKERS LEIN_ASTROCYTE_MARKERS	2.353	-1.057	-1.057	-1.057	0.254	-0.624	-1.057	-1.057	1.040	1.040	1.429
MCCLUNG_COCAINE_REWARD_5D MCCLUNG_COCAINE_REWARD_5D	-1.549	-3.111	0.850	-0.327	-1.091	0.276	-0.327	0.276	1.426	0.850	1.434
MACAEVA_PBMC_RESPONSE_TO_IR MACAEVA_PBMC_RESPONSE_TO_IR	-0.411	-0.810	-0.810	-0.810	-1.918	-1.460	0.323	1.593	1.309	2.998	0.326
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	-0.323	0.405	-2.040	-2.637	-0.651	0.280	-0.323	-0.323	0.405	1.458	3.200
COLLER_MYC_TARGETS_UP COLLER_MYC_TARGETS_UP	-0.994	1.744	2.357	1.213	-0.994	-0.994	-0.462	-0.204	-0.462	-0.462	-0.460
CHIBA_RESPONSE_TO_TSA CHIBA_RESPONSE_TO_TSA	1.320	-1.865	-0.676	1.320	-0.392	-1.865	-0.392	-0.676	1.320	0.958	0.227
YANG_BREAST_CANCER_ESR1_LASER_UP YANG_BREAST_CANCER_ESR1_LASER_UP	-0.671	2.878	-0.671	0.264	-0.341	-1.284	-1.284	0.264	2.266	-0.341	-0.340
MORI_IMMATURE_B_LYMPHOCYTE_UP MORI_IMMATURE_B_LYMPHOCYTE_UP	-1.294	-0.810	-0.492	-0.285	-0.810	-1.294	0.317	3.991	1.877	-0.285	-0.283
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	0.323	0.629	-0.280	5.309	-0.585	-1.918	0.323	-0.411	-0.585	-0.280	-1.453
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	-0.858	0.909	2.487	0.750	-0.539	-2.242	1.486	0.750	-1.883	-0.418	-1.052
LAIHO_COLORECTAL_CANCER_SERRATED_UP LAIHO_COLORECTAL_CANCER_SERRATED_UP	-1.358	-1.034	0.322	0.795	0.322	-2.256	0.452	2.456	2.116	-0.567	-1.027
DER_IFN_GAMMA_RESPONSE_UP DER_IFN_GAMMA_RESPONSE_UP	-1.424	-0.986	-0.276	1.592	0.328	-2.035	-1.424	0.499	1.961	1.259	-0.273
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	-1.699	-0.991	2.514	0.501	0.501	-0.574	0.783	0.783	0.285	-0.574	-1.695
AMIT_EGF_RESPONSE_60_HELA AMIT_EGF_RESPONSE_60_HELA	-0.729	0.370	0.370	-1.191	-1.191	-1.948	-0.431	1.620	2.561	-0.242	0.601
SEKI_INFLAMMATORY_RESPONSE_LPS_DN SEKI_INFLAMMATORY_RESPONSE_LPS_DN	-0.911	0.217	-0.406	-0.911	-0.406	-0.911	0.490	0.490	-0.911	0.873	3.346
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-1.999	-0.961	2.012	1.297	-0.422	-1.999	1.297	0.737	-0.422	-0.647	0.345
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	0.701	1.209	-0.266	0.701	-1.253	-1.253	-0.888	-0.412	-0.412	-1.739	3.551
VANTVEER_BREAST_CANCER_ESR1_UP VANTVEER_BREAST_CANCER_ESR1_UP	-0.886	-0.515	0.329	3.132	-2.200	-1.133	-1.133	0.582	2.151	0.329	-0.272
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	-1.699	0.285	0.783	0.783	-1.699	-0.991	-0.574	0.783	-0.318	2.514	-0.316
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	2.564	-0.580	-1.160	-0.580	0.978	0.607	-1.160	-0.580	-0.580	-0.580	1.437
GENTILE_UV_RESPONSE_CLUSTER_D4 GENTILE_UV_RESPONSE_CLUSTER_D4	-0.921	-0.921	1.652	2.543	-0.348	-2.239	0.435	0.944	-0.578	-0.578	-0.346
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	-0.418	-1.383	1.479	1.765	-0.582	-2.288	-0.582	2.771	-0.582	-0.291	-0.414
BOSCO_TH1_CYTOTOXIC_MODULE BOSCO_TH1_CYTOTOXIC_MODULE	2.501	-0.272	-1.732	-0.272	-0.393	0.467	-0.393	-2.843	0.333	-0.552	2.169
LI_AMPLIFIED_IN_LUNG_CANCER LI_AMPLIFIED_IN_LUNG_CANCER	-0.660	-1.288	-0.513	0.987	-0.392	-2.281	0.987	4.022	0.526	-0.392	-0.829
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	-0.994	0.426	1.213	1.744	-0.462	-0.462	1.213	0.426	-0.994	-0.994	-0.991
FOSTER_KDM1A_TARGETS_DN FOSTER_KDM1A_TARGETS_DN	-1.975	-0.586	0.692	2.932	0.341	-3.236	0.559	0.559	0.442	-0.739	0.565
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	-1.064	-0.732	2.619	3.071	0.445	-1.517	0.288	-0.732	0.288	-0.732	-0.727
LIU_SMARCA4_TARGETS LIU_SMARCA4_TARGETS	0.317	-0.810	-1.294	-0.285	0.521	0.317	-2.073	-0.492	1.095	-0.492	3.409
UEDA_PERIFERAL_CLOCK UEDA_PERIFERAL_CLOCK	-2.386	-0.285	0.423	2.227	0.318	-3.419	0.423	0.690	-0.662	0.853	0.553
GENTILE_UV_LOW_DOSE_UP GENTILE_UV_LOW_DOSE_UP	-1.036	-0.222	-0.491	0.726	-1.036	-1.036	1.149	-1.036	-0.222	1.658	1.153
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 MIKKELSEN_IPS_LCP_WITH_H3K4ME3	0.292	-0.415	-2.051	-2.051	0.292	0.646	-1.118	-0.545	0.509	1.612	3.051
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	-0.586	1.776	0.818	0.818	-1.891	-2.779	0.238	-0.374	0.581	0.818	-0.582
PEART_HDAC_PROLIFERATION_CLUSTER_UP PEART_HDAC_PROLIFERATION_CLUSTER_UP	-0.893	0.691	-0.556	1.706	0.455	-2.197	0.455	0.455	0.691	0.455	-2.191
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	0.344	0.451	-1.487	-0.976	-1.487	-1.487	-0.976	0.577	1.718	1.065	2.547
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	0.782	-1.420	-1.933	-1.420	-1.029	0.782	1.297	0.404	0.782	-0.731	1.953
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.610	-0.610	-1.202	-1.202	-0.610	-0.300	-0.610	0.302	1.877	1.877	1.369
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	0.936	0.291	-0.613	-2.351	-0.312	0.291	-0.613	-1.432	-0.829	2.326	2.338
GENTLES_LEUKEMIC_STEM_CELL_UP GENTLES_LEUKEMIC_STEM_CELL_UP	-0.300	0.572	-0.300	-0.610	-1.202	-1.202	-0.300	-1.202	1.365	0.572	2.467
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	-0.454	-0.689	1.549	2.309	-0.454	-2.986	-0.454	0.688	0.481	0.314	-1.007
GENTILE_UV_RESPONSE_CLUSTER_D7 GENTILE_UV_RESPONSE_CLUSTER_D7	-0.250	-0.477	0.614	4.181	-0.250	-1.533	-0.860	0.940	-0.477	-0.477	-0.857
DITTMER_PTHLH_TARGETS_UP DITTMER_PTHLH_TARGETS_UP	-1.704	-0.262	0.344	1.875	-0.381	-3.599	1.057	1.303	-0.381	0.344	-0.377
ELVIDGE_HYPOXIA_BY_DMOG_UP ELVIDGE_HYPOXIA_BY_DMOG_UP	-0.473	-1.416	-0.473	1.271	-1.104	-1.792	-0.342	-0.849	2.411	2.092	0.509
HOEBEKE_LYMPHOID_STEM_CELL_UP HOEBEKE_LYMPHOID_STEM_CELL_UP	-0.324	0.575	1.255	1.859	-1.278	-2.994	-0.324	0.575	0.575	0.412	-1.701
LUI_THYROID_CANCER_CLUSTER_4 LUI_THYROID_CANCER_CLUSTER_4	-0.378	-0.870	-0.870	-0.870	-0.378	2.725	-0.870	-0.378	0.930	0.527	0.933
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-1.296	0.676	0.676	1.272	-2.034	-2.515	0.283	2.375	0.391	0.283	-0.437
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	1.024	-0.659	-1.252	-0.461	-1.680	-0.313	-0.659	-0.659	0.290	0.793	4.421
HASLINGER_B_CLL_WITH_6Q21_DELETION HASLINGER_B_CLL_WITH_6Q21_DELETION	-0.911	0.873	3.338	0.490	-0.911	-0.911	0.217	0.217	-0.911	-0.406	0.218
BURTON_ADIPOGENESIS_8 BURTON_ADIPOGENESIS_8	-0.842	-0.577	-0.383	0.367	-2.326	-1.675	0.538	0.994	3.202	0.538	-0.242
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	1.575	-0.566	-0.751	-1.252	-0.418	2.789	-1.252	-0.977	-0.301	2.140	-0.745
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	0.345	-0.621	0.345	1.781	-0.798	-3.323	-0.261	-0.798	2.632	0.738	-0.615
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	-0.278	0.429	-0.373	-0.373	-1.249	-3.742	-0.634	0.551	0.429	2.759	1.230
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	-0.580	-1.160	-0.580	-0.280	-0.280	-0.580	0.978	3.971	0.324	0.324	-1.157
PLASARI_NFIC_TARGETS_BASAL_UP PLASARI_NFIC_TARGETS_BASAL_UP	0.324	1.432	-1.160	-0.580	-1.160	0.324	-0.280	-0.580	-1.160	0.978	1.968
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	-0.402	-0.525	-0.302	0.968	-3.253	-1.594	-0.525	0.399	0.514	2.956	0.807
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	2.148	-0.351	-0.828	-0.828	0.566	0.256	-0.828	-0.351	-0.351	-0.828	2.154
KINNEY_DNMT1_METHYLATION_TARGETS KINNEY_DNMT1_METHYLATION_TARGETS	-0.538	-0.538	-0.538	-0.176	-0.538	4.273	-0.176	-0.538	0.476	-0.538	0.478
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN	-0.663	-0.663	-0.663	-0.663	-0.247	-0.663	0.762	3.556	0.762	-0.247	-0.246
GALE_APL_WITH_FLT3_MUTATED_DN GALE_APL_WITH_FLT3_MUTATED_DN	-0.663	-0.663	-0.663	-0.247	-0.247	-0.663	3.556	0.762	-0.247	0.762	-0.661
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	0.750	-1.328	-0.837	0.498	-0.513	-0.513	-0.837	-1.328	-0.301	3.308	1.418
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	-0.671	-0.671	2.266	0.836	0.836	-1.284	0.509	0.836	-0.671	-0.671	-1.281
FLORIO_HUMAN_NEOCORTEX FLORIO_HUMAN_NEOCORTEX	4.433	0.389	-1.158	-1.158	-0.702	-0.228	-0.411	-0.228	-1.158	-0.228	0.924
LIU_VMYB_TARGETS_UP LIU_VMYB_TARGETS_UP	-0.963	0.610	2.368	1.470	-1.254	-3.227	0.610	-0.388	0.331	-0.273	-0.384
NAKAMURA_ADIPOGENESIS_LATE_UP NAKAMURA_ADIPOGENESIS_LATE_UP	-1.709	1.542	0.575	1.542	-0.940	-2.264	-0.476	-0.476	1.859	-0.324	-0.321
RODRIGUES_NTN1_AND_DCC_TARGETS RODRIGUES_NTN1_AND_DCC_TARGETS	-1.450	-0.219	-0.430	0.680	-1.450	-1.450	-0.219	1.449	1.449	0.680	-0.217
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	0.701	-0.412	-1.253	-0.266	-1.739	-2.400	0.339	0.701	0.701	0.339	2.647
JI_RESPONSE_TO_FSH_DN JI_RESPONSE_TO_FSH_DN	-0.893	0.272	1.319	1.706	-0.893	-2.197	0.272	1.706	-0.893	0.272	-0.553
LIU_CDX2_TARGETS_UP LIU_CDX2_TARGETS_UP	-0.219	-0.796	-1.450	-0.796	-0.796	3.081	0.680	-0.219	-0.796	-0.219	1.454
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	-0.434	-1.606	-1.064	-2.446	0.541	1.411	0.541	-0.434	0.346	0.784	1.418
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	-0.828	-0.234	-0.453	5.060	-0.234	-1.492	-0.234	0.380	-0.234	-0.234	-0.825
MORI_MATURE_B_LYMPHOCYTE_UP MORI_MATURE_B_LYMPHOCYTE_UP	-1.563	0.488	0.488	-0.589	-1.151	-2.807	1.731	1.138	0.889	-0.404	0.677
BHATTACHARYA_EMBRYONIC_STEM_CELL BHATTACHARYA_EMBRYONIC_STEM_CELL	0.301	0.301	1.112	2.886	0.451	-0.672	0.636	0.301	-1.836	-1.836	-1.329
KATSANOU_ELAVL1_TARGETS_DN KATSANOU_ELAVL1_TARGETS_DN	1.126	1.126	0.582	-0.275	-0.381	-1.429	-0.682	-1.133	-0.886	3.497	-1.420
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	-1.064	-1.606	-1.064	-1.606	0.541	0.784	0.346	-0.691	0.784	1.411	1.799
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP	0.369	-0.340	0.265	-0.817	-1.340	-2.089	-1.340	1.718	1.007	2.619	0.268
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	-0.733	0.453	1.130	1.130	-0.385	-1.367	0.453	0.453	1.130	-1.367	-1.364
LEIN_CHOROID_PLEXUS_MARKERS LEIN_CHOROID_PLEXUS_MARKERS	1.866	0.611	-1.120	-2.534	-1.487	-0.601	0.611	-0.424	1.866	-0.291	0.616
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	-0.282	-0.744	-0.282	0.321	-1.277	-1.635	-0.282	4.246	1.440	-0.282	-0.976
LI_CISPLATIN_RESISTANCE_DN LI_CISPLATIN_RESISTANCE_DN	2.092	-0.385	-0.733	-0.385	-1.367	0.231	-0.385	-1.367	-0.385	2.092	0.757
LENAOUR_DENDRITIC_CELL_MATURATION_UP LENAOUR_DENDRITIC_CELL_MATURATION_UP	0.983	-0.291	-0.418	-0.291	-1.383	-1.787	-1.787	-0.291	0.439	0.983	3.169
WALLACE_PROSTATE_CANCER_UP WALLACE_PROSTATE_CANCER_UP	0.279	2.269	-0.787	0.609	-0.787	-0.787	-0.787	1.057	-0.787	0.609	-0.323
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.596	0.520	-0.596	-0.865	-0.865	-2.363	-0.865	1.902	1.902	0.965	0.524
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	-0.316	-0.316	1.761	0.720	-0.316	-2.156	0.720	1.761	-0.535	-0.865	-1.357
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	-0.865	-0.535	0.286	0.286	-0.535	-2.156	1.017	3.220	0.720	-0.316	-0.861
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	0.422	-0.344	-0.546	-0.344	-0.546	-2.696	0.262	-1.241	1.876	0.627	1.885
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	-0.351	-0.828	0.991	1.521	-0.828	-0.828	0.256	2.148	-0.351	-0.828	-0.350
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	0.695	-0.813	1.091	2.168	-0.813	-3.404	-0.321	0.533	0.695	0.282	-1.056
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	-1.865	-0.392	1.320	1.736	0.409	-1.865	0.958	0.226	0.226	-0.392	-0.673
CROMER_METASTASIS_DN CROMER_METASTASIS_DN	-0.797	-1.144	0.253	0.798	-0.797	-1.144	2.444	-1.612	2.046	0.253	0.400
XIE_LT_HSC_S1PR3_OE_UP XIE_LT_HSC_S1PR3_OE_UP	-0.300	0.928	0.302	-1.202	-0.610	-1.202	-0.610	-0.300	0.302	-0.300	3.834
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	0.515	-1.928	-0.343	-0.483	-0.483	-1.928	-0.885	2.901	1.328	0.870	0.265
REICHERT_MITOSIS_LIN9_TARGETS REICHERT_MITOSIS_LIN9_TARGETS	-0.550	0.644	0.644	2.675	-0.260	-1.119	0.644	0.347	-1.119	-0.550	-1.116
LEE_METASTASIS_AND_RNA_PROCESSING_UP LEE_METASTASIS_AND_RNA_PROCESSING_UP	-0.663	-0.247	3.556	0.762	-0.247	-0.663	0.362	0.362	-0.663	-0.663	-0.661
ZAMORA_NOS2_TARGETS_UP ZAMORA_NOS2_TARGETS_UP	-1.501	-0.382	0.877	2.895	0.397	-1.501	1.190	0.397	-0.622	-0.622	-0.973
FOSTER_TOLERANT_MACROPHAGE_UP FOSTER_TOLERANT_MACROPHAGE_UP	-0.347	-0.464	0.468	-0.347	-3.291	-0.782	-1.241	0.355	0.926	2.365	1.340
KRASNOSELSKAYA_ILF3_TARGETS_UP KRASNOSELSKAYA_ILF3_TARGETS_UP	-1.658	-0.549	-0.300	-1.658	0.302	0.527	-0.958	0.302	1.176	2.069	0.530
CORRE_MULTIPLE_MYELOMA_UP CORRE_MULTIPLE_MYELOMA_UP	3.681	-0.577	-0.577	-0.842	-1.198	-0.383	-0.842	-0.577	-0.577	1.949	0.753
GNATENKO_PLATELET_SIGNATURE GNATENKO_PLATELET_SIGNATURE	-0.650	-0.650	-0.650	0.684	-0.650	-1.090	0.430	0.998	4.009	-0.373	-1.086
MARTIN_NFKB_TARGETS_DN MARTIN_NFKB_TARGETS_DN	-0.456	-0.456	0.187	-0.456	-0.456	-0.456	0.187	0.187	-0.456	4.918	0.188
LIU_COMMON_CANCER_GENES LIU_COMMON_CANCER_GENES	-1.211	-0.329	0.274	2.808	0.906	-2.654	0.440	-0.329	0.651	-0.527	-0.524
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	-1.243	-0.320	0.283	0.283	-1.243	-1.243	-0.640	0.880	1.301	1.796	0.284
DURAND_STROMA_NS_UP DURAND_STROMA_NS_UP	-0.798	1.534	-1.261	-0.261	-0.475	-1.901	-1.556	-0.261	0.587	2.046	1.545
LEE_LIVER_CANCER_DENA_DN LEE_LIVER_CANCER_DENA_DN	0.288	1.153	-2.144	-1.064	-0.488	0.878	-0.488	1.153	-1.064	-0.732	2.210
ZHAN_MULTIPLE_MYELOMA_UP ZHAN_MULTIPLE_MYELOMA_UP	0.274	1.205	0.440	2.349	-0.329	-2.654	0.440	-0.527	0.440	-0.810	-1.206
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-0.313	-1.364	-0.313	0.435	-0.691	-0.981	-2.547	2.034	0.615	0.831	1.374
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	0.515	-0.483	2.201	1.086	-0.661	-3.905	0.376	0.262	0.515	-0.885	0.265
WANG_TARGETS_OF_MLL_CBP_FUSION_DN WANG_TARGETS_OF_MLL_CBP_FUSION_DN	-1.865	0.226	1.736	2.204	-0.676	-1.124	-0.676	0.654	0.226	0.409	-0.673
MORI_MATURE_B_LYMPHOCYTE_DN MORI_MATURE_B_LYMPHOCYTE_DN	-1.549	0.428	0.276	3.004	0.276	-1.091	0.276	0.620	0.850	-0.506	-2.172
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	-1.606	-0.434	1.075	-0.434	-1.064	-1.606	0.784	2.676	-0.434	-0.260	0.789
HOELZEL_NF1_TARGETS_DN HOELZEL_NF1_TARGETS_DN	1.190	-0.810	-1.408	-0.598	0.577	-0.598	-1.408	-1.077	0.959	0.426	3.117
WINZEN_DEGRADED_VIA_KHSRP WINZEN_DEGRADED_VIA_KHSRP	0.921	-1.355	-1.355	-0.733	0.249	-0.360	-0.360	-1.798	0.707	2.429	1.447
LU_AGING_BRAIN_DN LU_AGING_BRAIN_DN	-0.993	-0.775	2.869	-0.329	-0.329	-1.255	1.947	0.809	0.275	-1.934	-0.325
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	-0.518	0.428	1.509	3.295	-2.091	-1.105	-1.105	-0.284	0.707	-0.388	-0.513
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	-0.432	-0.432	1.508	0.914	-0.327	-2.831	1.293	0.751	0.606	-0.432	-2.372
ROSS_LEUKEMIA_WITH_MLL_FUSIONS ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-0.865	0.353	0.520	1.902	-0.865	-3.319	-0.397	0.965	0.724	0.353	-0.394
LUCAS_HNF4A_TARGETS_UP LUCAS_HNF4A_TARGETS_UP	-1.035	-0.247	0.564	1.456	-1.035	-2.405	-0.247	-0.247	-0.668	1.456	1.118
ZHANG_PROLIFERATING_VS_QUIESCENT ZHANG_PROLIFERATING_VS_QUIESCENT	-0.782	-2.031	-0.271	-0.271	-0.271	-2.031	0.546	0.814	1.137	1.137	0.549
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	0.347	0.756	-0.823	0.756	-2.012	-1.318	-1.318	-0.482	0.347	1.133	2.761
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	-0.775	-0.341	1.387	0.412	-1.580	-2.217	0.598	0.412	1.387	1.087	-1.112
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	-0.702	0.920	-0.411	-1.158	1.677	-1.158	-1.907	-0.228	0.389	0.920	0.924
HOLLERN_PAPILLARY_BREAST_TUMOR HOLLERN_PAPILLARY_BREAST_TUMOR	-0.324	-0.324	-0.787	-0.787	2.269	0.279	-0.787	-0.787	0.609	-0.324	1.618
HEDENFALK_BREAST_CANCER_BRACX_UP HEDENFALK_BREAST_CANCER_BRACX_UP	0.279	-0.324	-0.787	-0.324	-0.787	-0.787	2.269	1.613	0.609	-0.324	-0.785
KIM_WT1_TARGETS_8HR_UP KIM_WT1_TARGETS_8HR_UP	-1.556	0.457	1.534	0.587	-1.010	-2.774	0.345	1.781	0.907	-0.475	-0.470
FINETTI_BREAST_CANCER_KINOME_GREEN FINETTI_BREAST_CANCER_KINOME_GREEN	-0.663	-0.663	0.362	-0.247	0.362	-0.663	-0.247	2.696	-0.663	1.292	-0.661
RUAN_RESPONSE_TO_TNF_DN RUAN_RESPONSE_TO_TNF_DN	-0.577	-0.244	-0.244	0.367	-0.383	-3.277	-0.244	-0.842	0.367	1.949	1.604
KYNG_DNA_DAMAGE_DN KYNG_DNA_DAMAGE_DN	-2.255	-1.551	1.006	1.198	-0.382	-1.877	1.006	1.198	0.832	-0.382	-0.282
LIM_MAMMARY_LUMINAL_MATURE_UP LIM_MAMMARY_LUMINAL_MATURE_UP	1.109	0.251	0.251	-0.508	-0.950	-0.357	-3.523	-0.357	0.882	2.284	0.254
RODRIGUES_DCC_TARGETS_DN RODRIGUES_DCC_TARGETS_DN	-0.866	-0.469	0.697	0.530	-1.142	-3.867	0.388	1.111	0.891	0.891	0.392
LEE_LIVER_CANCER_SURVIVAL_UP LEE_LIVER_CANCER_SURVIVAL_UP	0.914	1.508	-0.560	0.479	-0.898	-0.432	-0.327	-1.659	-2.385	0.479	2.274
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	-0.294	-0.389	0.797	3.528	-2.571	-1.011	-0.647	-0.389	-0.647	0.962	0.410
FU_INTERACT_WITH_ALKBH8 FU_INTERACT_WITH_ALKBH8	-0.538	-0.176	0.476	4.273	-0.176	-0.538	-0.538	-0.176	-0.176	-0.538	-0.537
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-1.403	-0.718	-0.319	0.497	-0.558	-2.495	0.785	0.382	2.677	1.357	-0.552
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	-0.704	-0.704	-0.272	-0.704	-0.272	-0.704	-0.704	0.706	1.206	1.821	0.708
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	-0.543	0.406	0.840	0.530	0.530	-3.765	0.530	1.230	1.025	-0.707	-1.415
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4 MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	-0.663	-0.663	2.696	0.762	-0.247	-0.663	0.362	-0.663	-0.247	0.762	-0.661
